Cargando…
Predictive and Experimental Immunogenicity of Burkholderia Collagen-like Protein 8-Derived Antigens
Burkholderia pseudomallei is an infectious bacterium of clinical and biodefense concern, and is the causative agent of melioidosis. The mortality rate can reach up to 50% and affects 165,000 people per year; however, there is currently no vaccine available. In this study, we examine the antigen-spec...
Autores principales: | Grund, Megan E., Kramarska, Eliza, Choi, Soo Jeon, McNitt, Dudley H., Klimko, Christopher P., Rill, Nathaniel O., Dankmeyer, Jennifer L., Shoe, Jennifer L., Hunter, Melissa, Fetterer, David P., Hedrick, Zander M., Velez, Ivan, Biryukov, Sergei S., Cote, Christopher K., Berisio, Rita, Lukomski, Slawomir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8621890/ https://www.ncbi.nlm.nih.gov/pubmed/34835150 http://dx.doi.org/10.3390/vaccines9111219 |
Ejemplares similares
-
Burkholderia collagen-like protein 8, Bucl8, is a
unique outer membrane component of a putative tetrapartite efflux pump in
Burkholderia pseudomallei and Burkholderia
mallei
por: Grund, Megan E., et al.
Publicado: (2020) -
Layered and integrated medical countermeasures against Burkholderia pseudomallei infections in C57BL/6 mice
por: Klimko, Christopher P., et al.
Publicado: (2022) -
Thinking Outside the Bug: Targeting Outer Membrane Proteins for Burkholderia Vaccines
por: Grund, Megan E., et al.
Publicado: (2021) -
Evaluation of two different vaccine platforms for immunization against melioidosis and glanders
por: Biryukov, Sergei S., et al.
Publicado: (2022) -
Efficacy of Treatment with the Antibiotic Novobiocin against Infection with Bacillus anthracis or Burkholderia pseudomallei
por: Klimko, Christopher P., et al.
Publicado: (2022)